Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 5.5T | 5.4T | 5.4T | 5.4T |
Cost of revenue | 4.4T | 4.2T | 4.2T | 4.3T |
Gross profit | 1.2T | 1.1T | 1.2T | 1.2T |
Operating expense | ||||
Research & development | 267.7B | 262.7B | 215.9B | 292.2B |
Selling general and admin | 514.8B | 629.3B | 495.8B | 552.5B |
Other operating expenses | — | — | — | — |
Operating income | 397.3B | 257.9B | 484.7B | 305.6B |
Non operating interest income | ||||
Income | 50.1B | 50.6B | 50.1B | 52.9B |
Expense | 13.0B | 12.8B | 12.2B | 27.6B |
Other income expense | -6.5B | -22.2B | 1.4B | 119.6B |
Pretax income | 483.6B | 182.5B | 559.5B | 377.9B |
Tax provision | 150.0B | 70.0B | 145.1B | 120.0B |
Net income | 333.6B | 112.5B | 414.3B | 257.9B |
Basic EPS | — | — | 245.4 | — |
Diluted EPS | — | — | 245.4 | — |
Basic average shares | — | — | 11.7B | — |
Diluted average shares | — | — | 11.7B | — |
EBITDA | 677.8B | 374.1B | 759.6B | 596.5B |
Net income from continuing op. | 483.6B | 182.5B | 559.5B | 377.9B |
Minority interests | -23B | -12.5B | -19.7B | -20.3B |
Preferred stock dividends | — | — | — | — |